{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:50Z","timestamp":1790356070181,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006398","name":"Roswell Park Alliance Foundation, Roswell Park Cancer Institute","doi-asserted-by":"publisher","award":["Roswell Park Alliance Foundation, Roswell Park Cancer Institute"],"award-info":[{"award-number":["Roswell Park Alliance Foundation, Roswell Park Cancer Institute"]}],"id":[{"id":"10.13039\/100006398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10147-026-03130-y","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:18:34Z","timestamp":1785507514000},"page":"2213-2222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of lymph node yield on biochemical recurrence in patients with high-risk prostate cancer after robot-assisted radical prostatectomy"],"prefix":"10.1007","volume":"31","author":[{"given":"Shuichi","family":"Morizane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Wasay","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kanehira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Wychowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayaan","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshid A.","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"3130_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"3130_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","volume":"8","author":"J Mohler","year":"2010","unstructured":"Mohler J, Bahnson RR, Boston B et al (2010) NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 8:162\u2013200","journal-title":"J Natl Compr Canc Netw"},{"key":"3130_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015770","volume":"98","author":"L Cao","year":"2019","unstructured":"Cao L, Yang Z, Qi L et al (2019) Robot-assisted and laparoscopic vs open radical prostatectomy in clinically localized prostate cancer: perioperative, functional, and oncological outcomes: a systematic review and meta-analysis. Medicine 98:e15770","journal-title":"Medicine"},{"key":"3130_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eururo.2012.02.029","volume":"62","author":"A Tewari","year":"2012","unstructured":"Tewari A, Sooriakumaran P, Bloch DA et al (2012) Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 62:1\u201315","journal-title":"Eur Urol"},{"key":"3130_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.eururo.2012.05.047","volume":"62","author":"G Novara","year":"2012","unstructured":"Novara G, Ficarra V, Mocellin S et al (2012) Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 62:382\u2013404","journal-title":"Eur Urol"},{"key":"3130_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/end.2022.0819","volume":"37","author":"TBC Moretti","year":"2023","unstructured":"Moretti TBC, Magna LA, Reis LO (2023) Open, laparoscopic, and robot-assisted radical prostatectomy oncological results: a reverse systematic review. J Endourol 37:521\u2013530","journal-title":"J Endourol"},{"key":"3130_CR7","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s10147-020-01682-1","volume":"25","author":"S Morizane","year":"2020","unstructured":"Morizane S, Honda M, Shimizu R et al (2020) Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer. Int J Clin Oncol 25:1398\u20131404","journal-title":"Int J Clin Oncol"},{"key":"3130_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/JU.0000000000000504","volume":"203","author":"F Preisser","year":"2020","unstructured":"Preisser F, van den Bergh RCN, Gandaglia G et al (2020) Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D\u2019Amico intermediate and high risk prostate cancer treated with radical prostatectomy: a multi-institutional study. J Urol 203:338\u2013343","journal-title":"J Urol"},{"key":"3130_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.eururo.2008.09.043","volume":"55","author":"A Briganti","year":"2009","unstructured":"Briganti A, Karnes JR, Da Pozzo LF et al (2009) Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 55:261\u2013270","journal-title":"Eur Urol"},{"key":"3130_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-022-02121-z","author":"S Morizane","year":"2022","unstructured":"Morizane S, Honda M, Shimizu R et al (2022) Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-022-02121-z","journal-title":"Int J Clin Oncol"},{"key":"3130_CR11","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969\u2013974","journal-title":"JAMA"},{"key":"3130_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1089\/end.2011.0589","volume":"26","author":"T Daimon","year":"2012","unstructured":"Daimon T, Miyajima A, Maeda T et al (2012) Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy? J Endourol 26:1199\u20131202","journal-title":"J Endourol"},{"key":"3130_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/iju.12112","volume":"20","author":"K Mitsuzuka","year":"2013","unstructured":"Mitsuzuka K, Koie T, Narita S et al (2013) Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer? Int J Urol 20:1092\u20131096","journal-title":"Int J Urol"},{"key":"3130_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618\u2013629","journal-title":"Eur Urol"},{"key":"3130_CR15","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1097\/01.ju.0000091805.98960.13","volume":"170","author":"I Cagiannos","year":"2003","unstructured":"Cagiannos I, Karakiewicz P, Eastham JA et al (2003) A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170:1798\u20131803","journal-title":"J Urol"},{"key":"3130_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","volume":"61","author":"A Briganti","year":"2012","unstructured":"Briganti A, Larcher A, Abdollah F et al (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61:480\u2013487","journal-title":"Eur Urol"},{"key":"3130_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.eururo.2020.03.023","volume":"78","author":"G Gandaglia","year":"2020","unstructured":"Gandaglia G, Martini A, Ploussard G et al (2020) External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection. Eur Urol 78:138\u2013142","journal-title":"Eur Urol"},{"key":"3130_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.eururo.2018.05.034","volume":"74","author":"W Wilczak","year":"2018","unstructured":"Wilczak W, Wittmer C, Clauditz T et al (2018) Marked prognostic impact of minimal lymphatic tumor spread in prostate cancer. Eur Urol 74:376\u2013386","journal-title":"Eur Urol"},{"key":"3130_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-01977-x","author":"S Morizane","year":"2021","unstructured":"Morizane S, Yumioka T, Makishima K et al (2021) Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-021-01977-x","journal-title":"Int J Clin Oncol"},{"key":"3130_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/iju.13514","volume":"25","author":"Y Murata","year":"2018","unstructured":"Murata Y, Tatsugami K, Yoshikawa M et al (2018) Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer. Int J Urol 25:284\u2013289","journal-title":"Int J Urol"},{"key":"3130_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/his.14901","volume":"82","author":"J Oufattole","year":"2023","unstructured":"Oufattole J, Dey T, D\u2019Amico AV et al (2023) Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with grade group 5 prostate cancer. Histopathology 82:1089\u20131097","journal-title":"Histopathology"},{"key":"3130_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/JU.0000000000001290","volume":"204","author":"N Miura","year":"2020","unstructured":"Miura N, Mori K, Mostafaei H et al (2020) The prognostic impact of intraductal carcinoma of the prostate: a systematic review and meta-analysis. J Urol 204:909\u2013917","journal-title":"J Urol"},{"key":"3130_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2022.01.028","volume":"531","author":"D Lowder","year":"2022","unstructured":"Lowder D, Rizwan K, McColl C et al (2022) Racial disparities in prostate cancer: a complex interplay between socioeconomic inequities and genomics. Cancer Lett 531:71\u201382","journal-title":"Cancer Lett"},{"key":"3130_CR24","first-page":"266","volume":"10","author":"K Gupta","year":"2022","unstructured":"Gupta K, Mehrotra V, Fu P et al (2022) Racial disparities in biochemical recurrence of prostate cancer. Am J Clin Exp Urol 10:266\u2013270","journal-title":"Am J Clin Exp Urol"},{"key":"3130_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euros.2022.07.005","volume":"44","author":"BC Ozdemir","year":"2022","unstructured":"Ozdemir BC, Arnold N, Fleischmann A et al (2022) Prediction of biochemical recurrence based on molecular detection of lymph node metastasis after radical prostatectomy. Eur Urol Open Sci 44:1\u201310","journal-title":"Eur Urol Open Sci"},{"key":"3130_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051117","author":"S Engels","year":"2021","unstructured":"Engels S, Brautmeier L, Reinhardt L et al (2021) Evaluation of fast molecular detection of lymph node metastases in prostate cancer patients using one-step nucleic acid amplification (OSNA). Cancers. https:\/\/doi.org\/10.3390\/cancers13051117","journal-title":"Cancers"},{"key":"3130_CR27","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1200\/JCO.21.01107","volume":"39","author":"P Kaul","year":"2021","unstructured":"Kaul P, Majumdar K, Kumar R et al (2021) Isolated tumor cells in sentinel lymph nodes: a management dilemma. J Clin Oncol 39:3517\u20133518","journal-title":"J Clin Oncol"},{"key":"3130_CR28","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41416-018-0052-7","volume":"118","author":"JS Liikanen","year":"2018","unstructured":"Liikanen JS, Leidenius MH, Joensuu H et al (2018) Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study. Br J Cancer 118:1529\u20131535","journal-title":"Br J Cancer"},{"key":"3130_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fsurg.2016.00065","volume":"3","author":"L Moris","year":"2016","unstructured":"Moris L, Van den Broeck T, Tosco L et al (2016) Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection. Front Surg 3:65","journal-title":"Front Surg"},{"key":"3130_CR30","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00345-015-1515-6","volume":"33","author":"RA Ledezma","year":"2015","unstructured":"Ledezma RA, Negron E, Razmaria AA et al (2015) Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes. World J Urol 33:1689\u20131694","journal-title":"World J Urol"},{"key":"3130_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41585-020-00384-7","volume":"17","author":"LJ Wilkins","year":"2020","unstructured":"Wilkins LJ, Tosoian JJ, Sundi D et al (2020) Surgical management of high-risk, localized prostate cancer. Nat Rev Urol 17:679\u2013690","journal-title":"Nat Rev Urol"},{"key":"3130_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.euros.2021.07.010","volume":"38","author":"M Terlizzi","year":"2022","unstructured":"Terlizzi M, Bossi A (2022) High-risk locally advanced prostate cancer: multimodal treatment is the key. Eur Urol Open Sci 38:14\u201316","journal-title":"Eur Urol Open Sci"},{"key":"3130_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12957-023-02932-y","volume":"21","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang G, Wang J et al (2023) Different lymph node dissection ranges during radical prostatectomy for patients with prostate cancer: a systematic review and network meta-analysis. World J Surg Oncol 21:80","journal-title":"World J Surg Oncol"},{"key":"3130_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11934-017-0696-5","volume":"18","author":"M Colicchia","year":"2017","unstructured":"Colicchia M, Sharma V, Abdollah F et al (2017) Therapeutic value of standard versus extended pelvic lymph node dissection during radical prostatectomy for high-risk prostate cancer. Curr Urol Rep 18:51","journal-title":"Curr Urol Rep"},{"key":"3130_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","volume":"72","author":"N Fossati","year":"2017","unstructured":"Fossati N, Willemse PM, Van den Broeck T et al (2017) The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol 72:84\u2013109","journal-title":"Eur Urol"},{"key":"3130_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","volume":"79","author":"JFP Lestingi","year":"2021","unstructured":"Lestingi JFP, Guglielmetti GB, Trinh QD et al (2021) Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial. Eur Urol 79:595\u2013604","journal-title":"Eur Urol"},{"key":"3130_CR37","first-page":"9340","volume":"25","author":"A Chenam","year":"2018","unstructured":"Chenam A, Ruel N, Pal S et al (2018) Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer. Can J Urol 25:9340\u20139348","journal-title":"Can J Urol"},{"key":"3130_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.790183","volume":"11","author":"G Yang","year":"2021","unstructured":"Yang G, Xie J, Guo Y et al (2021) Identifying the candidates who will benefit from extended pelvic lymph node dissection at radical prostatectomy among patients with prostate cancer. Front Oncol 11:790183","journal-title":"Front Oncol"},{"key":"3130_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clgc.2020.03.008","volume":"18","author":"J Kodiyan","year":"2020","unstructured":"Kodiyan J, Guirguis A, Ashamalla H (2020) Radical prostatectomy without pelvic lymph node dissection is widely practiced in high-risk patients despite poorer survival. Clin Genitourin Cancer 18:395-401 e398","journal-title":"Clin Genitourin Cancer"},{"key":"3130_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/CU9.0000000000000132","volume":"16","author":"RS Flammia","year":"2022","unstructured":"Flammia RS, Hoeh B, Chierigo F et al (2022) Differences in rates of pelvic lymph node dissection in National comprehensive cancer network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries. Curr Urol 16:191\u2013196","journal-title":"Curr Urol"},{"key":"3130_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","volume":"4","author":"GE Cacciamani","year":"2021","unstructured":"Cacciamani GE, Maas M, Nassiri N et al (2021) Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive systematic review and meta-analysis. Eur Urol Oncol 4:134\u2013149","journal-title":"Eur Urol Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03130-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:50:01Z","timestamp":1790355001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03130-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3130"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03130-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the author(s) used ChatGPT in order to enhance readability and check for grammatical errors. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":2,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}